1. Home
  2. CLF vs LQDA Comparison

CLF vs LQDA Comparison

Compare CLF & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cleveland-Cliffs Inc.

CLF

Cleveland-Cliffs Inc.

HOLD

Current Price

$9.95

Market Cap

4.9B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$78.11

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLF
LQDA
Founded
1847
2004
Country
United States
United States
Employees
25000
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.5B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
CLF
LQDA
Price
$9.95
$78.11
Analyst Decision
Hold
Strong Buy
Analyst Count
11
11
Target Price
$10.43
$41.00
AVG Volume (30 Days)
19.1M
2.4M
Earning Date
04-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.81
EPS
N/A
0.52
Revenue
$18,610,000,000.00
$158,320,000.00
Revenue This Year
$8.76
$278.87
Revenue Next Year
$2.64
$57.13
P/E Ratio
N/A
$147.92
Revenue Growth
N/A
1031.18
52 Week Low
$7.36
$11.85
52 Week High
$16.70
$78.25

Technical Indicators

Market Signals
Indicator
CLF
LQDA
Relative Strength Index (RSI) 33.67 75.44
Support Level $8.82 $31.23
Resistance Level $10.00 N/A
Average True Range (ATR) 0.72 4.14
MACD -0.47 0.40
Stochastic Oscillator 1.24 91.55

Price Performance

Historical Comparison
CLF
LQDA

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: